Financial Performance - Net profit attributable to shareholders was CNY 26,477,959.08, down 16.25% year-on-year[6]. - Operating revenue for the period was CNY 70,454,860.94, representing a decline of 37.05% compared to the same period last year[6]. - The net profit after deducting non-recurring gains and losses was CNY 25,162,949.03, down 18.97% year-on-year[6]. - The company's net profit from investment increased significantly to CNY 5.29 million, up 1706.56% from CNY 0.29 million year-on-year, primarily due to gains from the disposal of long-term equity investments[16]. - Total operating revenue for Q1 2019 was ¥70,454,860.94, a decrease of 37% compared to ¥111,926,381.39 in Q1 2018[28]. - Net profit for Q1 2019 was ¥26,308,541.27, a decline of 16% from ¥31,574,329.11 in Q1 2018[29]. - Total profit for Q1 2019 was ¥29,753,434.13, down 20% from ¥36,993,756.17 in Q1 2018[29]. - The basic and diluted earnings per share for Q1 2019 were ¥0.0661, compared to ¥0.0790 in Q1 2018[30]. Cash Flow - The net cash flow from operating activities was negative CNY 48,569,318.25, a significant decrease of 1,344.17% year-on-year[6]. - The net cash flow from operating activities was -52,196,452.81 RMB, a significant decline compared to 26,463,307.07 RMB in the same period last year, indicating a negative cash flow trend[36]. - The total cash outflow from operating activities reached 76,406,053.17 RMB, compared to 25,562,928.88 RMB in the previous year, indicating a substantial increase in cash outflows[36]. - The company reported a total cash inflow from operating activities of 24,209,600.36 RMB, down from 52,026,235.95 RMB year-over-year, indicating a decline in operational performance[36]. - The company received 19,178,293.78 RMB from other operating activities, a significant increase from 3,668,084.66 RMB in the previous year, showing improved cash inflow from this segment[36]. - The company paid 57,061,608.24 RMB in other operating cash payments, a notable rise from 13,458,278.12 RMB in the same quarter last year, indicating increased operational costs[36]. - Cash and cash equivalents dropped significantly from CNY 17,512,665.93 to CNY 2,536,493.18, a decrease of approximately 85.5%[25]. - Cash and cash equivalents at the end of the period were 2,536,493.18 RMB, down from 51,831,190.52 RMB at the end of the same quarter last year, reflecting a decrease of approximately 95%[37]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,235,967,627.94, a decrease of 0.99% compared to the end of the previous year[6]. - Current liabilities decreased from CNY 288,616,418.24 to CNY 247,967,849.68, a reduction of about 14.1%[23]. - Non-current liabilities decreased from CNY 40,129,821.91 to CNY 37,290,338.66, a decrease of approximately 7.2%[23]. - Total liabilities decreased from CNY 328,746,240.15 to CNY 285,258,188.34, a decline of around 13.2%[23]. - The company's total current assets as of March 31, 2019, were CNY 602.82 million, a slight decrease from CNY 620.65 million at the end of 2018[21]. - The balance of prepaid accounts at the end of the reporting period was CNY 32.77 million, an increase of 183.78% from CNY 11.55 million at the beginning of the period, mainly due to prepaid purchase amounts[15]. - The balance of other receivables increased to CNY 6.14 million, a rise of 229.07% from CNY 1.87 million at the beginning of the period, mainly due to receivables from the transfer of 51% equity in Tianjin Trading Company[15]. - The balance of accounts payable decreased to CNY 46.60 million, down 36.18% from CNY 73.02 million at the beginning of the period, mainly due to the reduction in the scope of consolidation after the equity transfer[15]. - Total equity increased from CNY 919,584,505.06 to CNY 950,709,439.60, an increase of approximately 3.4%[23]. Shareholder Information - The total number of shareholders at the end of the reporting period was 18,998[12]. - The largest shareholder, Xinjiang Production and Construction Corps, held 19.86% of the shares[12]. Other Income and Gains - The company reported non-recurring gains of CNY 1,315,010.05 for the period[11]. - The company reported other income of CNY 1.56 million, an increase of 2038.27% from CNY 0.07 million year-on-year, mainly due to government subsidies from Nanjing Huawei Company[16]. - Investment income for Q1 2019 was ¥5,289,590.05, compared to ¥292,846.62 in Q1 2018, indicating a substantial increase[28].
百花医药(600721) - 2019 Q1 - 季度财报